Cabergoline Tablet
Product Images NDC 70512-860

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 70512-860). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sola Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cabergoline 01)

Chemical structure diagram of cabergoline, the active ingredient in the product Cabergoline 0.5 mg tablet from SOLA Pharmaceuticals, LLC. The diagram shows the molecular configuration with rings and functional groups characteristic of cabergoline.*

FDA Label Image

Label (Label)

Cabergoline 0.5 mg tablet label showing NDC 70512-860-08, containing 8 tablets. It is a prescription oral tablet manufactured by SOLA Pharmaceuticals, LLC. The label includes dosage strength, storage instructions, and distribution details in Baton Rouge, LA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.